Treatment of breakthrough cancer pain: to titrate or to proportionate?
作者： Guy H. Hans
DOI: 10.1185/03007995.2013.837816
关键词:
摘要: Breakthrough cancer pain can be treated effectively by rapid-onset opioids, such as sublingual fentanyl. However, it remained unclear how the optimal dose of fentanyl should determined. Dosing proportional to basic opioid regimen is now proposed an alternative titration.
informahealthcare.com参考文章(17)
T. Beutlhauser, J. Oeltjenbruns, M. Schäfer, Durchbruchschmerzen und kurz wirksame Opioide Anaesthesist. ,vol. 62, pp. 431- 439 ,(2013) , 10.1007/S00101-013-2193-7
Patt Rb, Ellison Nm, Breakthrough pain in cancer patients: characteristics, prevalence, and treatment. Oncology. ,vol. 12, pp. 1035- 1046 ,(1998)
Tone Rustøen, Jenske I. Geerling, Theodora Pappa, Carina Rundström, Isolde Weisse, Sian C. Williams, Bostjan Zavratnik, Ulf E. Kongsgaard, Yvonne Wengström, A European survey of oncology nurse breakthrough cancer pain practices. European Journal of Oncology Nursing. ,vol. 17, pp. 95- 100 ,(2013) , 10.1016/J.EJON.2012.05.005
Fausto Meriggi, Alberto Zaniboni, Fentanyl for breakthrough cancer pain: where are we? Reviews on Recent Clinical Trials. ,vol. 8, pp. 42- 47 ,(2013) , 10.2174/15748871112079990039
Sebastiano Mercadante, Giovanna Prestia, Alessandra Casuccio, The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen Current Medical Research and Opinion. ,vol. 29, pp. 1527- 1532 ,(2013) , 10.1185/03007995.2013.826640
Andrew N. Davies, Andrew Dickman, Colette Reid, Anna-Marie Stevens, Giovambattista Zeppetella, The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland European Journal of Pain. ,vol. 13, pp. 331- 338 ,(2009) , 10.1016/J.EJPAIN.2008.06.014
Russell K. Portenoy, MD, Daniel Bruns, PsyD, Bonnie Shoemaker, BSN, Steven A. Shoemaker, MD, Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 2: Impact on function, mood, and quality of life Journal of opioid management. ,vol. 6, pp. 109- 116 ,(2010) , 10.5055/JOM.2010.0010
Giovambattista Zeppetella, Catherine A O'Doherty, Silke Collins, Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. Journal of Pain and Symptom Management. ,vol. 20, pp. 87- 92 ,(2000) , 10.1016/S0885-3924(00)00161-5
Frank Elsner, Giovambattista Zeppetella, Josep Porta-Sales, Ignacio Tagarro, Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients Clinical Drug Investigation. ,vol. 31, pp. 605- 618 ,(2011) , 10.2165/11592910-000000000-00000
Nora M. Hagelberg, Klaus T. Olkkola, Fentanyl for breakthrough cancer pain: what's new? Pain. ,vol. 151, pp. 565- 566 ,(2010) , 10.1016/J.PAIN.2010.08.026